Actively Recruiting
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Led by IRCCS Eugenio Medea · Updated on 2025-01-30
20
Participants Needed
2
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hereditary Spastic Paraplegia (HSP) is a diverse group of genetic neurological conditions causing progressive weakness and spasticity in the lower limbs, severely reducing balance and gait capabilities. There is currently a lack of structured neurorehabilitation programs aimed at improving gait in adults with HSP. This protocol seeks to assess the feasibility and effectiveness of a structured training approach focusing on flexibility, muscle strength, motor control, balance, and aerobic capacity. To this end, twenty adults diagnosed with HSP will engage in 10 to 16 sessions, each lasting 60 to 120 minutes, guided by a therapist once or twice a week, depending on individual preferences. At the end of the program, participants will receive a transfer package, including written instructions (a manual) and video tutorials, to encourage ongoing exercise at home. Assessments will occur before the intervention (T0), immediately after (T1), and three months later (T2). The primary outcomes will measure the feasibility of the program, including recruitment, retention, adherence, the absence of adverse events, and patient satisfaction. Secondary outcomes will focus on improvements in gait capabilities such as gait endurance and gait speed.
CONDITIONS
Official Title
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults diagnosed with Hereditary Spastic Paraplegia
- Functional deficits in the lower limbs affecting walking, such as muscle weakness, high muscle tone, or balance problems
- Ability to walk independently without physical assistance (Functional Ambulation Category score 3 or higher)
- Ability to understand simple instructions, willing to participate, complete at least 10 treatment sessions, and able to sign informed consent
You will not qualify if you...
- Received botulinum toxin or surgery for lower limb hypertonia within 6 months before enrollment
- Medical conditions preventing moderate physical activity like stretching, muscle strengthening, or aerobic exercise
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Scientific Institute, IRCCS E. Medea, Department of Bosisio Parini, Lecco, Italy.
Bosisio Parini, Lombardy, Italy, 23842
Actively Recruiting
2
Scientific Institute, IRCCS E. Medea, Department of Pieve di Soligo, Treviso, Italy
Pieve di Soligo, Veneto, Italy, 31053
Actively Recruiting
Research Team
L
Leonardo Boccuni, PhD
CONTACT
M
Marco Bortolini, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here